Global stock markets are flat this morning as the count of coronavirus cases rose in multiple major economies, resulting in more business limitations.
Independent monitors temporarily halted enrollment Tuesday in testing Eli Lilly and Co.’s (NYSE: LLY) COVID-19 experimental antibody therapy “out of an abundance of caution.” This came after Johnson & Johnson (NYSE: JNJ) paused its late-stage vaccine study due to a participant’s “unexplained illness.”
But virus vaccine setbacks aren’t the only thing hanging over the stock market…
In today’s video, I’ll show you how COVID-19 is impacting the major indexes… how earnings are influencing the overall market… a warning sign on current momentum levels in large-cap tech stocks… and two low-risk entry opportunities with risk stops.
I just sent WealthPress’s Jeff Yastine a text demanding he meet with me ASAP.
What I have to tell him won’t make some of my ties in the White House happy…
But a Wall Street legend and myself have over 400,000 readers to think about… And with $15 trillion at stake, this could make many of our subscribers extremely wealthy.